Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00484783 · ClinicalTrials.gov registry record · NA
Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT00484783: Completed NA study, sponsored by University Hospitals Cleveland Medical Center.
NCT00484783 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00484783, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
NOTES access is safe and feasible in the controlled human setting and comparable to standard-of-care surgical techniques. NOTES exploration of the abdomen provides adequate visualization comparable to laparoscopy.
Primary Outcome
* Number of successful NOTES access attempts * Number of failed NOTES access attempts * Injury to collateral organs or structures * Time to gain access to peritoneal cavity * Necessary balloon dilator size required for translumenal passage of endoscope
Interventions
- PROCEDURE Natural Orifice Transluminal Endoscopic Surgery (NOTES)
- PROCEDURE Natural Orifice Translumenal Endoscopic Surgery (NOTES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-01 |
| Phase | NA |
What the finished NCT00484783 record still lists
NCT00484783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Natural Orifice Transluminal Endoscopic Surgery (NOTES) is the first listed.
NCT00484783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00484783 about?
NCT00484783 is a clinical study titled "Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery". NOTES access is safe and feasible in the controlled human setting and comparable to standard-of-care surgical techniques. NOTES exploration of the abdomen provides adequate visualization comparable to laparoscopy.
What is the current status of trial NCT00484783?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2006-08. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00484783?
The interventions under investigation include: Natural Orifice Transluminal Endoscopic Surgery (NOTES) (PROCEDURE), Natural Orifice Translumenal Endoscopic Surgery (NOTES) (PROCEDURE).
Who is sponsoring clinical trial NCT00484783?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00484783's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia